Current Allergy and Asthma Reports

, Volume 8, Issue 4, pp 306–311

What causes itch in atopic dermatitis?

Article

Abstract

Itch, the hallmark of atopic dermatitis, has a significant impact on quality of life for patients with this disease. Various central and peripheral mediators have been suggested to play a role in the pathophysiology of atopic eczema itch. Significant cross-talk occurs among stratum corneum, keratinocytes, immune cells, and nerve fibers, which are in close proximity to one another and induce itch. The impaired barrier function associated with the itch-scratch cycle further augments this vicious cycle. Recent advances in our understanding of itch pathophysiology shed light on peripheral and central neural sensitization of nerve fibers that contribute significantly to itch in atopic dermatitis. Recently, several new mediators have been described as associated with itch in atopic dermatitis, including serine proteases, interleukin 31, and nerve growth factor. This review covers the peripheral and central mechanisms and mediators involved in pathogenesis of itch in atopic dermatitis.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Boguniewicz M: Atopic dermatitis: beyond the itch that rashes. Immunol Allergy Clin North Am 2005, 25:333–351, vii.PubMedCrossRefGoogle Scholar
  2. 2.
    Ikoma A, Steinhoff M, Städer S, et al.: The neurobiology of itch. Nat Rev Neurosci 2006, 7:535–547.PubMedCrossRefGoogle Scholar
  3. 3.
    Patel T, Ishiuji Y, Yosipovitch G: Nocturnal itch: why do we itch at night? Acta Derm Venereol 2007, 87:295–298.PubMedCrossRefGoogle Scholar
  4. 4.
    Lee CH, Chuang HY, Shih CC, et al.: Transepidermal water loss, serum IgE and beta-endorphin as important and independent biological markers for development of itch intensity in atopic dermatitis. Br J Dermatol 2006, 154:1100–1107.PubMedCrossRefGoogle Scholar
  5. 5.
    Yosipovitch G, Xiong GL, Haus E, et al.: Time-dependent variations of the skin barrier function in humans: transepidermal water loss, stratum corneum hydration, skin surface pH, and skin temperature. J Invest Dermatol 1998, 110:20–23.PubMedCrossRefGoogle Scholar
  6. 6.
    Stefansson K, Brattsand M, Roosterman D, et al.: Activation of proteinase-activated receptor-2 by human kallikreinrelated peptidases. J Invest Dermatol 2008, 128:18–25.PubMedCrossRefGoogle Scholar
  7. 7.
    Steinhoff M, Neisius U, Ikoma A, et al.: Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. J Neurosci 2003, 23:6176–6180.PubMedGoogle Scholar
  8. 8.
    Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al.: Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006, 38:441–446.PubMedCrossRefGoogle Scholar
  9. 9.
    Yosipovitch G: Dry skin and impairment of barrier function associated with itch: new insights. Int J Cosmetic Sci 2004, 26:1–7.CrossRefGoogle Scholar
  10. 10.
    Schmid-Wendtner MH, Korting HC: The pH of the skin surface and its impact on the barrier function. Skin Pharmacol Physiol 2006, 19:296–302.PubMedCrossRefGoogle Scholar
  11. 11.
    Hachem JP, Man MQ, Crumrine D, et al.: Sustained serine proteases activity by prolonged increase in pH leads to degradation of lipid processing enzymes and profound alterations of barrier function and stratum corneum integrity. J Invest Dermatol 2005, 125:510–520.PubMedCrossRefGoogle Scholar
  12. 12.
    Yosipovitch G: The pruritus receptor unit: a target for novel therapies. J Invest Dermatol 2007, 27:1857–1859.CrossRefGoogle Scholar
  13. 13.
    Andoh T, Kuraishi Y: Substance P and itch. In Itch: Basic Mechanisms and Therapy. Edited by Yosipovitch G, Greaves MW, Fleischer AB, et al.: New York: Marcel Dekker; 2004:87–95.Google Scholar
  14. 14.
    Schmelz M, Schmidt R, Bickel A, et al.: Specific C-receptors for itch in human skin. J Neurosci 1997, 17:8003–8008.PubMedGoogle Scholar
  15. 15.
    Klein PA, Clark RA: An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. Arch Dermatol 1999, 135:1522–1525.PubMedCrossRefGoogle Scholar
  16. 16.
    Johanek LM, Meyer RA, Hartke T, et al.: Psychophysical and physiological evidence for parallel afferent pathways mediating the sensation of itch. J Neurosci 2007, 27:7490–7497.PubMedCrossRefGoogle Scholar
  17. 17.
    Davidson S, Zhang X, Yoon CH, et al.: The itch-producing agents histamine and cowhage activate separate populations of primate spinothalamic tract neurons. J Neurosci 2007, 27:10007–10014.PubMedCrossRefGoogle Scholar
  18. 18.
    Leknes SG, Bantick S, Willis CM, et al.: Itch and motivation to scratch: an investigation of the central and peripheral correlates of allergen-and histamine-induced itch in humans. J Neurophysiol 2007, 97:415–422.PubMedCrossRefGoogle Scholar
  19. 19.
    Paus R, Schmelz M, Biro T, et al.: Frontiers in pruritus research: scratching the brain for more effective itch therapy. J Clin Invest 2006, 116:1174–1186.PubMedCrossRefGoogle Scholar
  20. 20.
    Ishiuji Y, Coghill RC, Patel T, et al.: Itch-related brain activity in patients with atopic eczema. J Invest Derm, 127(Suppl 1):S8–S8.Google Scholar
  21. 21.
    Hanifin JM, Thurston M, Omoto M, et al.: The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group. Exp Dermatol 2001, 10:11–18.PubMedCrossRefGoogle Scholar
  22. 22.
    Yosipovitch G, Ishiuji Y, Patel TS: The brain processing of scratching. J Invest Dermatol 2008 (Epub ahead of print).Google Scholar
  23. 23.
    Toyoda M, Nakamura M, Makino T, et al.: Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol 2002, 147:71–79.PubMedCrossRefGoogle Scholar
  24. 24.
    Urashima R, Mihara M: Cutaneous nerves in atopic dermatitis. A histological, immunohistochemical and electron microscopic study. Virchows Arch 1998, 432:363–370.PubMedCrossRefGoogle Scholar
  25. 25.
    Yosipovitch G, Duque MI, Fast K: Remote noxious heat stimuli and scratching inhibit itch response in humans. Br J Dermatol 2007, 156:629–634.PubMedCrossRefGoogle Scholar
  26. 26.
    Ishiuji Y, Coghill RC, Patel T, et al.: Repetitive scratching and noxious heat do not inhibit histamine-induced itch in atopic dermatitis. Br J Dermatol 2008, 158:78–83.PubMedGoogle Scholar
  27. 27.
    Hosogi M, Schmelz M, Miyachi Y, et al.: Bradykinin is a potent pruritogen in atopic dermatitis: A switch from pain to itch. Pain 2006, 126:16–23.PubMedCrossRefGoogle Scholar
  28. 28.
    Simone DA, Alreja M, Lamotte RH: Psychophysical studies of the itch sensation and itchy skin (“alloknesis”) produced by intracutaneous injection of histamine. Somatosens Mot Res 1991, 8:271–279.PubMedCrossRefGoogle Scholar
  29. 29.
    Yosipovitch G, Greaves MW, Schmelz M: Itch. Lancet 2003, 361:690–694.PubMedCrossRefGoogle Scholar
  30. 30.
    Schmelz M, Handwerker HO: Pain and itch. In Itch: Basic Mechanisms and Therapy. Edited by Yosipovitch G, Greaves MW, Fleischer AB, et al.: New York: Marcel Dekker; 2004:13–20.Google Scholar
  31. 31.
    Dunford PJ, Williams KN, Desai PJ, et al.: Histamine H4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus. J Allergy Clin Immunol 2007, 119:176–183.PubMedCrossRefGoogle Scholar
  32. 32.
    Bell JK, McQueen DS, Rees JL: Involvement of histamine H4 and H1 receptors in scratching induced by histamine receptor agonists in Balb C mice. Br J Pharmacol 2004, 142:374–380.PubMedCrossRefGoogle Scholar
  33. 33.
    Städer S, Steinhoff M: Pathophysiology of pruritus in atopic dermatitis: an overview. Exp Dermatol 2002, 11:12–24.CrossRefGoogle Scholar
  34. 34.
    Sonkoly E, Muller A, Lauerma I: IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 2006, 117:411–417.PubMedCrossRefGoogle Scholar
  35. 35.
    Arita K, South AP, Hans-Filho G et al.: Oncostatin M receptor-beta mutations underlie familial primary localized cutaneous amyloidosis. J Am J Hum Genet 2008, 82:73–80.CrossRefGoogle Scholar
  36. 36.
    Raap U, Goltz C, Deneka N, et al.: Brain-derived neurotrophic factor is increased in atopic dermatitis and modulates eosinophil functions compared with that seen in nonatopic subjects. J Allergy Clin Immunol 2005, 115:1268–1275.PubMedCrossRefGoogle Scholar
  37. 37.
    Steinhoff M, Bienenstock J, Schmelz M, et al.: Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus. J Invest Dermatol 2006, 126:1705–1718.PubMedCrossRefGoogle Scholar
  38. 38.
    Tominaga M, Ogawa H, Takamori K: Possible roles of epidermal opioid systems in pruritus of atopic dermatitis. J Invest Dermatol 2007, 127:2228–2235.PubMedCrossRefGoogle Scholar
  39. 39.
    Bigliardi, PL, Stammer H, Jost G, et al.: Treatment of pruritus with topically applied opiate receptor antagonist. J Am Acad Dermatol 2007, 56:979–988.PubMedCrossRefGoogle Scholar
  40. 40.
    Heyer GF, Ulmer J, Schmitz J, et al.: Histamine-induced itch and alloknesis (itchy skin) in atopic eczema patients and controls. Acta Derm Venereol 1995, 75:348–352.PubMedGoogle Scholar
  41. 41.
    Rukwied R, Heyer G, et al.: Administration of acetylcholine and vasoactive intestinal polypeptide to atopic eczema patients. Exp Dermatol 1999, 8:39–45.PubMedCrossRefGoogle Scholar
  42. 42.
    Kirchner A, Stefan H, Schmelz M, et al.: Influence of vagus nerve stimulation on histamine-induced itching. Neurology 2002, 59:108–112.PubMedCrossRefGoogle Scholar
  43. 43.
    Neisius UR, Olsson R, Rukwied G, et al.: Prostaglandin E2 induces vasodilation and pruritus, but no protein extravasation in atopic dermatitis and controls. J Am Acad Dermatol 2002, 47:28–32.PubMedCrossRefGoogle Scholar
  44. 44.
    Andoh T, Nishikawa Y, Yamaguchi-Miyamoto T, et al.: Thromboxane A2 induces itch-associated responses through TP receptors in the skin in mice. J Invest Dermatol 2007, 127:2042–2047.PubMedCrossRefGoogle Scholar
  45. 45.
    Sugimoto M, Arai I, Futaki N, et al.: Putative mechanism of the itch-scratch circle: repeated scratching decreases the cutaneous level of prostaglandin D2, a mediator that inhibits itching. Prostaglandins Leukot Essent Fatty Acids 2007, 76:93–101.PubMedCrossRefGoogle Scholar
  46. 46.
    Jävikallio A, Harvima IT, Naukkarinen A: Mast cells, nerves and neuropeptides in atopic dermatitis and nummular eczema. Arch Dermatol Res 2003, 295:2–7.Google Scholar
  47. 47.
    Salomon J, Baran E: The role of selected neuropeptides in pathogenesis of atopic dermatitis. J Eur Acad Dermatol Venereol 2008, 22:223–228.PubMedGoogle Scholar
  48. 48.
    Bíró T, Tóth BI, Marincsák R, et al.: TRP channels as novel players in the pathogenesis and therapy of itch. Biochim Biophys Acta 2007 1772:1004–1021.PubMedGoogle Scholar
  49. 49.
    Amano H, Negishi I, Akiyama H, et al.: Psychological stress can trigger atopic dermatitis in Nc/Nga mice: an inhibitory effect of corticotropin-releasing factor. Neuropsychopharmacology 2008, 33:566–573.PubMedCrossRefGoogle Scholar
  50. 50.
    Pavlovic S, Daniltchenko M, Tobin DJ, et al.: Further exploring the brain-skin connection: stress worsens dermatitis via substance P-dependent neurogenic inflammation in mice. J Invest Dermatol 2008, 128:434–446.PubMedCrossRefGoogle Scholar
  51. 51.
    Slominski A: A nervous breakdown in the skin: stress and the epidermal barrier. J Clin Invest 2007, 117:3166–3169.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  1. 1.Departments of Dermatology and Neurobiology and AnatomyWake Forest University School of MedicineWinston-SalemUSA

Personalised recommendations